Schedule 13G ownership disclosure

Tyra Biosciences Inc

COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 90240B106

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Canaan XI L.P.

    Shares: 3,731,165 · Class: 7.4%

  • Canaan Partners XI LLC

    Shares: 3,731,165 · Class: 7.4%

  • Canaan 2020+ Co-Investment L.P. - Series 7

    Shares: 448,692 · Class: 0.9%

  • Canaan Partners 2020+ Co-Investment LLC

    Shares: 448,692 · Class: 0.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-007278
Form type
SCHEDULE 13G/A
Filer
Canaan XI L.P.
CIK
CIK 1712417
Filed
Jan 21, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub